Search Results 331-340 of 16362 for monoclonal antibody

1. Mayo experts encouraged by authorization of first pill to treat COVID-19

   And unlike monoclonal antibodies, it should retain efficacy against variants," says Dr. Priya Sampathkumar, a Mayo Clinic infectious diseases specialist ...

2. Pseudomembranous colitis - Diagnosis & treatment - Mayo Clinic

   The U.S. Food and Drug Administration (FDA) has approved the use of the human monoclonal antibody bezlotoxumab to reduce the risk of recurrence of C.

3. Three new high-tech tools for state scientists from Minnesota Partnership - Mayo Clinic News Network

   Researchers: Jeffrey Salisbury, Ph.D., Mayo Clinic; Claudia Neuhauser, Ph.D., University of Minnesota. Antibody phage display for monoclonal antibodies.

4. Focus Areas - T Cell Engineering Laboratory - Mayo Clinic Research

   These include secondary modification of CAR -T cells and combination strategies with monoclonal antibodies, small molecules, peptides and other ...

5. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...

6. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, interfere with the ability of cancer cells to grow and spread. It is not yet known whether fludarabine phosphate ...

7. Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia - Mayo Clinic

   Monoclonal antibodies, such as blinatumomab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether standard ...

8. Clinical trials - Hematology

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer ... Monoclonal B Cell Lymphocytosis (MBL) and B-Chronic Lymphocytic Leukemia ...

9. Crohn's disease - Diagnosis and treatment - Mayo Clinic

   Risankizumab also is a monoclonal antibody. This medicine acts against a molecule known as interleukin-23. Risankizumab was recently approved for treating ...

10. Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma - Mayo Clinic

    Monoclonal antibodies, such as ganitumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as ...